E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 2/1/2006 in the Prospect News Biotech Daily.

Cardica lowers IPO price talk to $10-$12 per share from $12-$14 per share

By Ted A. Knutson

Washington, Feb. 1 - Cardica, Inc. lowered the price talk for its pending initial public offering to $10 to $12 per share from $12 to $14 per share for 3.5 million shares in an amendment to its S-1 registration with the Securities and Exchange Commission.

The number of shares stays at 3.5 million while the greenshoe is for up to 525,000 shares.

A.G. Edwards and Allen & Co. LLC are the underwriters with the new addition of Montgomery & Co.

Cardica said lowering the price talk cuts the estimated net proceeds to the company at the midpoint of talk to $34 million from $40.5 million without the greenshoe or a reduction to $39.4 million from $46.8 million with the greenshoe.

The company has applied for the stock to be quoted on the Nasdaq National Market under the symbol "CRDC."

Cardica, a Redwood City, Calif.-based firm, designs and manufactures proprietary automated anastomotic systems used by surgeons to perform coronary artery bypass surgery.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.